{"id":4936,"date":"2026-01-06T11:07:11","date_gmt":"2026-01-06T01:07:11","guid":{"rendered":"\/eu-uk\/?p=4936"},"modified":"2026-01-06T11:07:11","modified_gmt":"2026-01-06T01:07:11","slug":"orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m","status":"publish","type":"post","link":"\/eu-uk\/blog\/2026\/01\/06\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\/","title":{"rendered":"Orthocell Records Seventh Consecutive Quarter of Record Revenue at $3.2m"},"content":{"rendered":"<p><span data-contrast=\"auto\">Orthocell\u00a0Limited (ASX:OCC) has\u00a0commenced\u00a02026 with another strong result, delivering its seventh consecutive quarter of record revenue.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">For the quarter ended 31 December 2025, the Company achieved record quarterly revenue of $3.2 million,\u00a0representing\u00a0a 7.0% increase on the prior quarterly record and a 45.2% increase on the prior corresponding period. This outcome reflects a compound quarterly growth rate of 10.4% since Q3 FY24.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Key highlights for the period include:\u00a0<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"5\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"4\" data-aria-level=\"1\"><span data-contrast=\"auto\">Continued revenue growth driven by\u00a0strong performance\u00a0in established markets, particularly Australia\u00a0<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"5\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"5\" data-aria-level=\"1\"><span data-contrast=\"auto\">Meaningful progress in the U.S. commercialisation of\u00a0Remplir\u2122, including:<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"o\" data-font=\"Courier New\" data-listid=\"5\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:1440,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Courier New&quot;,&quot;469769242&quot;:[9675],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;o&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"1\" data-aria-level=\"2\"><span data-contrast=\"auto\">A distributor network that now covers 25+ States and 40% of the US population\u00a0<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"o\" data-font=\"Courier New\" data-listid=\"5\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:1440,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Courier New&quot;,&quot;469769242&quot;:[9675],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;o&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"2\" data-aria-level=\"2\"><span data-contrast=\"auto\">Submission of 61 applications to hospital Value Analysis Committees (VAC) in progress, of which 23 have been approved, ahead of schedule\u00a0<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"o\" data-font=\"Courier New\" data-listid=\"5\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:1440,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Courier New&quot;,&quot;469769242&quot;:[9675],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;o&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"3\" data-aria-level=\"2\"><span data-contrast=\"auto\">Completion of 11 major medical education meetings in key U.S. states introducing surgeons to\u00a0Remplir\u2019s\u00a0advanced nerve repair capabilities and clinical evidence supporting improved surgical workflow and patient care<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"5\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"6\" data-aria-level=\"1\"><span data-contrast=\"auto\">Appointment of a second Canadian distributor, positioning the Company for\u00a0initial\u00a0sales in the March quarter FY26 and steady adoption through 2026.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><span data-contrast=\"auto\">Orthocell\u00a0ended the quarter with $49.4 million in cash, no debt, and expects to receive an R&amp;D tax incentive refund of approximately $3.0 million in the March quarter FY26, providing strong financial capacity to support continued commercial expansion.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Orthocell\u00a0CEO and MD, Paul Anderson, said:\u00a0<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">\u201cThe seventh consecutive record revenue result for the December quarter is particularly pleasing, driven by\u00a0strong performance\u00a0in existing markets and early\u00a0Remplir\u00a0unit sales in the U.S. Early U.S. results show our hybrid market entry strategy, combining specialist\u00a0distributors with internal field leadership, is successful and delivering positive momentum. With the U.S. momentum building and Canada coming online, we see significant upside as we replicate the successful Australia and Singapore approach on a larger scale in the U.S.\u201d<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><a href=\"https:\/\/cdn-api.markitdigital.com\/apiman-gateway\/ASX\/asx-research\/1.0\/file\/2924-03043576-6A1306079&amp;v=undefined\"><span data-contrast=\"auto\">Click to read the ASX release.<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>For the quarter ended 31 December 2025, the Company achieved record quarterly revenue of $3.2 million,\u00a0representing\u00a0a 7.0% increase on the prior quarterly record and a 45.2% increase on the prior corresponding period. This outcome reflects a compound quarterly growth rate of 10.4% since Q3 FY24.<\/p>\n","protected":false},"author":2,"featured_media":4909,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-4936","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-news"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.8 - aioseo.com -->\n\t<meta name=\"description\" content=\"For the quarter ended 31 December 2025, the Company achieved record quarterly revenue of $3.2 million, representing a 7.0% increase on the prior quarterly record and a 45.2% increase on the prior corresponding period. This outcome reflects a compound quarterly growth rate of 10.4% since Q3 FY24.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Orthocell\"\/>\n\t<link rel=\"canonical\" href=\"\/eu-uk\/blog\/2026\/01\/06\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.8\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_GB\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Orthocell EU\/UK -\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Orthocell Records Seventh Consecutive Quarter of Record Revenue at $3.2m - Orthocell EU\/UK\" \/>\n\t\t<meta property=\"og:description\" content=\"For the quarter ended 31 December 2025, the Company achieved record quarterly revenue of $3.2 million, representing a 7.0% increase on the prior quarterly record and a 45.2% increase on the prior corresponding period. This outcome reflects a compound quarterly growth rate of 10.4% since Q3 FY24.\" \/>\n\t\t<meta property=\"og:url\" content=\"\/eu-uk\/blog\/2026\/01\/06\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-01-06T01:07:11+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-01-06T01:07:11+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Orthocell Records Seventh Consecutive Quarter of Record Revenue at $3.2m - Orthocell EU\/UK\" \/>\n\t\t<meta name=\"twitter:description\" content=\"For the quarter ended 31 December 2025, the Company achieved record quarterly revenue of $3.2 million, representing a 7.0% increase on the prior quarterly record and a 45.2% increase on the prior corresponding period. This outcome reflects a compound quarterly growth rate of 10.4% since Q3 FY24.\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2026\\\/01\\\/06\\\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\\\/#blogposting\",\"name\":\"Orthocell Records Seventh Consecutive Quarter of Record Revenue at $3.2m - Orthocell EU\\\/UK\",\"headline\":\"Orthocell Records Seventh Consecutive Quarter of Record Revenue at $3.2m\",\"author\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/wp-content\\\/uploads\\\/sites\\\/6\\\/2025\\\/10\\\/60.png\",\"width\":2000,\"height\":1429},\"datePublished\":\"2026-01-06T11:07:11+10:00\",\"dateModified\":\"2026-01-06T11:07:11+10:00\",\"inLanguage\":\"en-GB\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2026\\\/01\\\/06\\\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2026\\\/01\\\/06\\\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\\\/#webpage\"},\"articleSection\":\"Company News\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2026\\\/01\\\/06\\\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/company-news\\\/#listItem\",\"name\":\"Company News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/company-news\\\/#listItem\",\"position\":2,\"name\":\"Company News\",\"item\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/company-news\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2026\\\/01\\\/06\\\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\\\/#listItem\",\"name\":\"Orthocell Records Seventh Consecutive Quarter of Record Revenue at $3.2m\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2026\\\/01\\\/06\\\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\\\/#listItem\",\"position\":3,\"name\":\"Orthocell Records Seventh Consecutive Quarter of Record Revenue at $3.2m\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/category\\\/company-news\\\/#listItem\",\"name\":\"Company News\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#organization\",\"name\":\"Orthocell EU\\\/UK\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/\",\"name\":\"Orthocell\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2026\\\/01\\\/06\\\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0aab809366bb46167bf34d1c56223f53c568b96a5870f19d01139e3e4a20c2f1?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Orthocell\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2026\\\/01\\\/06\\\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\\\/#webpage\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2026\\\/01\\\/06\\\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\\\/\",\"name\":\"Orthocell Records Seventh Consecutive Quarter of Record Revenue at $3.2m - Orthocell EU\\\/UK\",\"description\":\"For the quarter ended 31 December 2025, the Company achieved record quarterly revenue of $3.2 million, representing a 7.0% increase on the prior quarterly record and a 45.2% increase on the prior corresponding period. This outcome reflects a compound quarterly growth rate of 10.4% since Q3 FY24.\",\"inLanguage\":\"en-GB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2026\\\/01\\\/06\\\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/author\\\/hcartres\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/wp-content\\\/uploads\\\/sites\\\/6\\\/2025\\\/10\\\/60.png\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2026\\\/01\\\/06\\\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\\\/#mainImage\",\"width\":2000,\"height\":1429},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/blog\\\/2026\\\/01\\\/06\\\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\\\/#mainImage\"},\"datePublished\":\"2026-01-06T11:07:11+10:00\",\"dateModified\":\"2026-01-06T11:07:11+10:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#website\",\"url\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/\",\"name\":\"Orthocell EU\\\/UK\",\"inLanguage\":\"en-GB\",\"publisher\":{\"@id\":\"https:\\\/\\\/orthocell.com\\\/eu-uk\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Orthocell Records Seventh Consecutive Quarter of Record Revenue at $3.2m - Orthocell EU\/UK","description":"For the quarter ended 31 December 2025, the Company achieved record quarterly revenue of $3.2 million, representing a 7.0% increase on the prior quarterly record and a 45.2% increase on the prior corresponding period. This outcome reflects a compound quarterly growth rate of 10.4% since Q3 FY24.","canonical_url":"\/eu-uk\/blog\/2026\/01\/06\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"\/eu-uk\/blog\/2026\/01\/06\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\/#blogposting","name":"Orthocell Records Seventh Consecutive Quarter of Record Revenue at $3.2m - Orthocell EU\/UK","headline":"Orthocell Records Seventh Consecutive Quarter of Record Revenue at $3.2m","author":{"@id":"\/eu-uk\/blog\/author\/hcartres\/#author"},"publisher":{"@id":"\/eu-uk\/#organization"},"image":{"@type":"ImageObject","url":"\/eu-uk\/wp-content\/uploads\/sites\/6\/2025\/10\/60.png","width":2000,"height":1429},"datePublished":"2026-01-06T11:07:11+10:00","dateModified":"2026-01-06T11:07:11+10:00","inLanguage":"en-GB","mainEntityOfPage":{"@id":"\/eu-uk\/blog\/2026\/01\/06\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\/#webpage"},"isPartOf":{"@id":"\/eu-uk\/blog\/2026\/01\/06\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\/#webpage"},"articleSection":"Company News"},{"@type":"BreadcrumbList","@id":"\/eu-uk\/blog\/2026\/01\/06\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/orthocell.com\/eu-uk#listItem","position":1,"name":"Home","item":"https:\/\/orthocell.com\/eu-uk","nextItem":{"@type":"ListItem","@id":"\/eu-uk\/blog\/category\/company-news\/#listItem","name":"Company News"}},{"@type":"ListItem","@id":"\/eu-uk\/blog\/category\/company-news\/#listItem","position":2,"name":"Company News","item":"\/eu-uk\/blog\/category\/company-news\/","nextItem":{"@type":"ListItem","@id":"\/eu-uk\/blog\/2026\/01\/06\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\/#listItem","name":"Orthocell Records Seventh Consecutive Quarter of Record Revenue at $3.2m"},"previousItem":{"@type":"ListItem","@id":"https:\/\/orthocell.com\/eu-uk#listItem","name":"Home"}},{"@type":"ListItem","@id":"\/eu-uk\/blog\/2026\/01\/06\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\/#listItem","position":3,"name":"Orthocell Records Seventh Consecutive Quarter of Record Revenue at $3.2m","previousItem":{"@type":"ListItem","@id":"\/eu-uk\/blog\/category\/company-news\/#listItem","name":"Company News"}}]},{"@type":"Organization","@id":"\/eu-uk\/#organization","name":"Orthocell EU\/UK","url":"\/eu-uk\/"},{"@type":"Person","@id":"\/eu-uk\/blog\/author\/hcartres\/#author","url":"\/eu-uk\/blog\/author\/hcartres\/","name":"Orthocell","image":{"@type":"ImageObject","@id":"\/eu-uk\/blog\/2026\/01\/06\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/0aab809366bb46167bf34d1c56223f53c568b96a5870f19d01139e3e4a20c2f1?s=96&d=mm&r=g","width":96,"height":96,"caption":"Orthocell"}},{"@type":"WebPage","@id":"\/eu-uk\/blog\/2026\/01\/06\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\/#webpage","url":"\/eu-uk\/blog\/2026\/01\/06\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\/","name":"Orthocell Records Seventh Consecutive Quarter of Record Revenue at $3.2m - Orthocell EU\/UK","description":"For the quarter ended 31 December 2025, the Company achieved record quarterly revenue of $3.2 million, representing a 7.0% increase on the prior quarterly record and a 45.2% increase on the prior corresponding period. This outcome reflects a compound quarterly growth rate of 10.4% since Q3 FY24.","inLanguage":"en-GB","isPartOf":{"@id":"\/eu-uk\/#website"},"breadcrumb":{"@id":"\/eu-uk\/blog\/2026\/01\/06\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\/#breadcrumblist"},"author":{"@id":"\/eu-uk\/blog\/author\/hcartres\/#author"},"creator":{"@id":"\/eu-uk\/blog\/author\/hcartres\/#author"},"image":{"@type":"ImageObject","url":"\/eu-uk\/wp-content\/uploads\/sites\/6\/2025\/10\/60.png","@id":"\/eu-uk\/blog\/2026\/01\/06\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\/#mainImage","width":2000,"height":1429},"primaryImageOfPage":{"@id":"\/eu-uk\/blog\/2026\/01\/06\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\/#mainImage"},"datePublished":"2026-01-06T11:07:11+10:00","dateModified":"2026-01-06T11:07:11+10:00"},{"@type":"WebSite","@id":"\/eu-uk\/#website","url":"\/eu-uk\/","name":"Orthocell EU\/UK","inLanguage":"en-GB","publisher":{"@id":"\/eu-uk\/#organization"}}]},"og:locale":"en_GB","og:site_name":"Orthocell EU\/UK -","og:type":"article","og:title":"Orthocell Records Seventh Consecutive Quarter of Record Revenue at $3.2m - Orthocell EU\/UK","og:description":"For the quarter ended 31 December 2025, the Company achieved record quarterly revenue of $3.2 million, representing a 7.0% increase on the prior quarterly record and a 45.2% increase on the prior corresponding period. This outcome reflects a compound quarterly growth rate of 10.4% since Q3 FY24.","og:url":"\/eu-uk\/blog\/2026\/01\/06\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\/","article:published_time":"2026-01-06T01:07:11+00:00","article:modified_time":"2026-01-06T01:07:11+00:00","twitter:card":"summary_large_image","twitter:title":"Orthocell Records Seventh Consecutive Quarter of Record Revenue at $3.2m - Orthocell EU\/UK","twitter:description":"For the quarter ended 31 December 2025, the Company achieved record quarterly revenue of $3.2 million, representing a 7.0% increase on the prior quarterly record and a 45.2% increase on the prior corresponding period. This outcome reflects a compound quarterly growth rate of 10.4% since Q3 FY24."},"aioseo_meta_data":[],"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/orthocell.com\/eu-uk\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"\/eu-uk\/blog\/category\/company-news\/\" title=\"Company News\">Company News<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tOrthocell Records Seventh Consecutive Quarter of Record Revenue at $3.2m\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/orthocell.com\/eu-uk"},{"label":"Company News","link":"\/eu-uk\/blog\/category\/company-news\/"},{"label":"Orthocell Records Seventh Consecutive Quarter of Record Revenue at $3.2m","link":"\/eu-uk\/blog\/2026\/01\/06\/orthocell-records-seventh-consecutive-quarter-of-record-revenue-at-3-2m\/"}],"_links":{"self":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4936","targetHints":{"allow":["GET"]}}],"collection":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/comments?post=4936"}],"version-history":[{"count":1,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4936\/revisions"}],"predecessor-version":[{"id":4937,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4936\/revisions\/4937"}],"wp:featuredmedia":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/media\/4909"}],"wp:attachment":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/media?parent=4936"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/categories?post=4936"},{"taxonomy":"post_tag","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/tags?post=4936"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}